Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy. [electronic resource]
Producer: 20010322Description: 88-90 p. digitalISSN:- 1524-9557
- Adolescent
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Child
- Demography
- Disease Susceptibility
- Drug Resistance, Neoplasm
- Female
- Humans
- Injections, Intravenous
- Interleukin-2 -- administration & dosage
- Male
- Melanoma -- drug therapy
- Middle Aged
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.